Bridge to Life Raises $110 Million Series C, Led by Soleus Capital, to Support VitaSmart™ Expansion in Liver Transplantation.
PRIVATEAug 12, 2026
Amount Raised
$110 Million
Round Type
Series C
Northbrookresearch
Investors
Soleus Capital Credit Opportunities FundLauxera Capital PartnersSoleus Capital
Description
Bridge to Life™ Ltd. has successfully completed a $110 million Series C funding round, aimed at launching the VitaSmart™ system and advancing its product pipeline. The funding was led by Soleus Capital, with contributions from Lauxera Capital Partners and internal stakeholders. This financing will help enhance their operations and provide working capital for U.S
Company Information
Company
Bridge to Life Ltd
Location
707 Skokie Blvd
Northbrook, Illinois, United States
About
Bridge to Life Ltd. is a private company based in Northbrook, Illinois, established in 2009. The company focuses on improving organ transplantation outcomes by developing and licensing advanced organ preservation solutions and technologies. With around 166 employees, Bridge to Life generates estimated revenues of approximately $16.1 million.
The company's mission is to enhance the viability and longevity of human organs during transport for transplantation. It offers a range of specialized products designed for organ procurement organizations and transplant centers, ensuring organs remain alive and functional during transport. Bridge to Life serves a global customer base, exporting its products to over 37 countries, and has received recognition for its export success, including the President’s E Award from the U.S. Department of Commerce. The company is committed to innovation in the medical device and healthcare sectors, collaborating with government agencies to support its international growth.
Fundz sees it the moment Bridge to Life Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Northbrookresearch